Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,64 AUD | -3,03 % | -1,54 % | +19,63 % |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 01/05/12 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Thomas Jarrett
COO | Chief Operating Officer | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/12 |
Justin Ward
BRD | Director/Board Member | - | 01/01/16 |
Director/Board Member | - | 29/11/17 | |
Daniel Astudillo
SAM | Sales & Marketing | - | 01/04/18 |
Maggie Niewidok
SEC | Corporate Secretary | - | 01/09/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Prendergast
CHM | Chairman | 70 | 24/04/18 |
Alan Dunton
BRD | Director/Board Member | 70 | 14/07/20 |
Director/Board Member | - | 29/11/17 | |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/12 |
James Graham
CEO | Chief Executive Officer | - | 01/05/12 |
Justin Ward
BRD | Director/Board Member | - | 01/01/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 203 701 863 | 125 456 123 ( 61,59 %) | 0 | 61,59 % |
Coordonnées société
Recce Pharmaceuticals Ltd.
Salesforce Tower 180 George Street
2000, Sydney
+61 2 9256 2505
http://www.recce.com.auSecteur
Ventes par région
Révisions de BNA
Bénéfices annuels - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
+19,63 % | 87,43 M | |
+33,25 % | 699 Md | |
+25,64 % | 571 Md | |
-3,55 % | 364 Md | |
+18,16 % | 326 Md | |
+4,36 % | 286 Md | |
+15,43 % | 236 Md | |
+5,54 % | 198 Md | |
-9,78 % | 194 Md | |
-3,69 % | 149 Md |
- Bourse
- Actions
- Action RCE
- Société Recce Pharmaceuticals Ltd